Angela Stoyanovitch's guest appearances

Angela Stoyanovitch

Legal Drugs Podcast

Molecular Moments Podcast

Dave Williams

David Johnson

Brandon Miller

Jeff Sutherland

Charles Sabine

Jim McNally

Lewis Parker

Jeff Marshall

Tom Leach

Ben Burton

Jeff Galvin

Jim Datin

Andre Ghetti

Vijaya Kumar Pidugu

Chris Mathes

OwlTail

In today’s episode, Chad sits down with Angela Stoyanovitch, a director of business development at BioAgilytix and founder of the Legal Drugs podcast. She’s a podcaster, veteran business developer, social media strategist and consultant who kicked off her career in research who has held business development roles across pre-clinical research, bioanalysis and in basic research. They discuss how she fell in love with the service side of research and her advice for others interested the drug industry.See omnystudio.com/listener for privacy information.

In today’s episode, Chad sits down with Angela Stoyanovitch, a director of business development at BioAgilytix and founder of the Legal Drugs podcast. She’s a podcaster, veteran business developer, social media strategist and consultant who kicked off her career in research who has held business development roles across pre-clinical research, bioanalysis and in basic research. They discuss how she fell in love with the service side of research and her advice for others interested the drug industry.See <a href="https://omnystudio.com/listener" rel="nofollow" target="_blank">omnystudio.com/listener</a> for privacy information.

Angela Stoyanovitch talks Detroit Pride, Legal Drugs, and the Google of CROs

Over the month of October 2020, Legal Drugs Podcast (LDP), a production of Legal Drugs Agency, LLC (LDA), was on a strategic sabbatical to give back and reorganize.  In this episode, Host, Angela Stoyanovitch, recaps the lasted COVID cure announcements with new drugs announced from both Pfizer and Moderna (biotech and pharma companies.) Unusually, their announcements included 90-95% efficacy of the vaccines which were developed at record speeds.  While drugs of any kind have had longer development periods in the past, Legal Drugs Podcast has continually highlighted that the increased speeds can be attributed to many variables - the most obvious is the use of technology, machine learning and A.I. for early drug discovery.  To the general public who is outside of the drug development industry, this all may seem mysterious and confusing but we explain that this is a manifestation of the use of creative scientific theory and understanding of DNA, etc. No longer will we rely on simple chemical compounding for drugs.  The future of legal drugs is curative drugs and we are in a space race within the biotech industry to find them! This is an exciting time in history to be a witness to such speedy developments and with a global threat such as the COVID-19 pandemic, the pressure (and funding) are on high! Together, we will continue to discuss these advancements in bite side portions as we have in the first 31 episodes of the show, Legal Drugs Podcast.  As Angela outlines in this episode, 32, we are looking to the future for more gene editing that will result in more gene and cell therapies. This Spring 2021, Legal Drugs Agency will produce a new livestream salon-styled intimate conference on gene therapies via LDA partner, PharmaSalon. If you know someone you'd like to recommend as a speaker, please reach out to our host, angela@legaldrugsagency.com. If you are in the market for a career change within the life sciences industry, specifically, the drug development and contract research organization niche, Angela would love to introduce you to our LDA partner, RPM ReSearch Solutions, for career coaching, resources and matching to open candidate roles.  This Fall 2020, we are launching our YouTube channel as a result of our efforts over the last month.  Stay tuned for more information and subscribe now @legaldrugspodcast on YouTube and Instagram to stay up to date on our announcements.   Thank you to those who have supported LDP as a patron on www.patreon.com/legaldrugspodcast.  Your support means the world to us and we wouldn't be here without your generous contributions that help us create more content.  Thank you!  Other sabbatical work includes two recordings with Angela on Lab Rat Chat, an interview with their podcast hosts where Angela dives deep into her career and life story - listen here for free;  Chat with Legal Drugs Podcast on Lab Rat Chat Podcast - and a podcast panel discussion recording as a platform session for the National Annual Meeting for the American Association for Laboratory Animal Science (AALAS) - read more on page 26 of the virtual program; NAALAS Panel Discussion: Podcasting to the Public. Finally, LDA was established with the idea that we highlight the heartbeat of biomedical research and the drug development continuum. What do we do this work? Why do we study new drugs and how do we give back? No matter how you slice it, legal drugs has an impact on all of us.  For those of us deep in our drug development work or corporate lives, it is easy to lose touch with that heartbeat or the stories of people's lives we impact one way or another.  This is the legal drugs business we discuss here but what about the illegal drug business on the streets affecting people in great need due to addictions and mental illness. We all can have a positive impact (great or small) on each other's mental and emotional health. As Host Angela has a great passion for groups of both animals and women in need, she often volunteers for these various causes.  While on sabbatical these last 4-6 weeks, Angela describes a new event she hosted to raise hygiene donations for women on the streets. This fundraising event was called Girls Giving and it resulting in over $300 of tampons and sanitary napkins that will be distributed by Restore Global as organized by iServewithJoy nonprofits in the metro-Charlotte, NC area.  Thank you for listening, downloading and reviewing our episodes.  Check out our new landing page at www.podpage.com/site/legal-drugs-podcast for more episodes! 

Over the month of October 2020, Legal Drugs Podcast (LDP), a production of Legal Drugs Agency, LLC (LDA), was on a strategic sabbatical to give back and reorganize.  In this episode, Host, Angela Stoyanovitch, recaps the lasted COVID cure announcements with new drugs announced from both Pfizer and Moderna (biotech and pharma companies.) Unusually, their announcements included 90-95% efficacy of the vaccines which were developed at record speeds.  While drugs of any kind have had longer development periods in the past, Legal Drugs Podcast has continually highlighted that the increased speeds can be attributed to many variables - the most obvious is the use of technology, machine learning and A.I. for early drug discovery.  To the general public who is outside of the drug development industry, this all may seem mysterious and confusing but we explain that this is a manifestation of the use of creative scientific theory and understanding of DNA, etc. No longer will we rely on simple chemical compounding for drugs.  The future of legal drugs is curative drugs and we are in a space race within the biotech industry to find them! This is an exciting time in history to be a witness to such speedy developments and with a global threat such as the COVID-19 pandemic, the pressure (and funding) are on high! Together, we will continue to discuss these advancements in bite side portions as we have in the first 31 episodes of the show, Legal Drugs Podcast.  As Angela outlines in this episode, 32, we are looking to the future for more gene editing that will result in more gene and cell therapies. This Spring 2021, Legal Drugs Agency will produce a new livestream salon-styled intimate conference on gene therapies via LDA partner, PharmaSalon. If you know someone you'd like to recommend as a speaker, please reach out to our host, <a href="mailto:angela@legaldrugsagency.com.">angela@legaldrugsagency.com.</a> If you are in the market for a career change within the life sciences industry, specifically, the drug development and contract research organization niche, Angela would love to introduce you to our LDA partner, RPM ReSearch Solutions, for career coaching, resources and matching to open candidate roles.  This Fall 2020, we are launching our YouTube channel as a result of our efforts over the last month.  Stay tuned for more information and subscribe now @legaldrugspodcast on YouTube and Instagram to stay up to date on our announcements.   Thank you to those who have supported LDP as a patron on <a href="http://www.patreon.com/legaldrugspodcast" rel="nofollow" target="_blank">www.patreon.com/legaldrugspodcast</a>.  Your support means the world to us and we wouldn't be here without your generous contributions that help us create more content.  Thank you!  Other sabbatical work includes two recordings with Angela on Lab Rat Chat, an interview with their podcast hosts where Angela dives deep into her career and life story - listen here for free; <a href="https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5idXp6c3Byb3V0LmNvbS83NzI2NzMucnNz/episode/QnV6enNwcm91dC02MjUxMjk2?hl=en&amp;ved=2ahUKEwi-v5WJ0YntAhVGVc0KHQONBBAQieUEegQIBRAF&amp;ep=6" rel="nofollow" target="_blank"> Chat with Legal Drugs Podcast on Lab Rat Chat Podcast</a> - and a podcast panel discussion recording as a platform session for the National Annual Meeting for the American Association for Laboratory Animal Science (AALAS) - read more on page 26 of the virtual program; <a href="https://issuu.com/aalasoffice/docs/2020_virtual_meeting_program" rel="nofollow" target="_blank">NAALAS Panel Discussion: Podcasting to the Public.</a> Finally, LDA was established with the idea that we highlight the heartbeat of biomedical research and the drug development continuum. What do we do this work? Why do we study new drugs and how do we give back? No matter how you slice it, legal drugs has an impact on all of us.  For those of us deep in our drug development work or corporate lives, it is easy to lose touch with that heartbeat or the stories of people's lives we impact one way or another.  This is the legal drugs business we discuss here but what about the illegal drug business on the streets affecting people in great need due to addictions and mental illness. We all can have a positive impact (great or small) on each other's mental and emotional health. As Host Angela has a great passion for groups of both animals and women in need, she often volunteers for these various causes.  While on sabbatical these last 4-6 weeks, Angela describes a new event she hosted to raise hygiene donations for women on the streets. This fundraising event was called Girls Giving and it resulting in over $300 of tampons and sanitary napkins that will be distributed by Restore Global as organized by iServewithJoy nonprofits in the metro-Charlotte, NC area.  Thank you for listening, downloading and reviewing our episodes.  Check out our new landing page at <a href="http://www.podpage.com/site/legal-drugs-podcast" rel="nofollow" target="_blank">www.podpage.com/site/legal-drugs-podcast</a> for more episodes!

32. How Legal Drugs are Making History Faster Than Ever Before & Why Legal Drugs Agency Cares by Angela Stoyanovitch 

This week's episode discusses the crux of the legal drug industry with an example of a growing global issue, antimicrobial resistance. This is a casual book review of the book, Superbugs, An Arms Race Against Bacteria, written by William Hall, Anthony McDonnell and Jim O'Neill published by Harvard University Press, copyright 2018. After being gifted the book, host, Angela Stoyanovitch, falls in love with the topic of antibiotics, a category type of legal drugs. According to the book, Superbugs, approximately 1.5 million people die every year already as a result of antimicrobial resistance. The antibiotic crisis is still developing today.  Is it possible that many of us have abused antibiotics at some point? Are the right diagnostic tests in place within our health care provider systems? What's happening worldwide with resistant strains of bacteria? Do we even know what bacterial strains we are handling or up against as the bacteria evolves so rapidly? What responsibility do we have as individuals? What role does or should our governments play? What about the drug development industry or pharmaceutical companies? In order to understand this issue more fully, perhaps a systems thinking approach should be taken (a reference from a book titled, Thinking in Systems: A Primer, written by Donella Meadows.) As with any drug development topic, this one is complex but applicable to our everyday lives.  Listen in to learn more about Superbugs and potential solutions to this silent killer that include simple human behavioral changes such as hand washing up to a massive cry for global government, pharmaceutical and academic collaboration and funding for new legal drugs, etc.  This episode of Legal Drugs Podcast edited by Margaret Beveridge. 

This week's episode discusses the crux of the legal drug industry with an example of a growing global issue, antimicrobial resistance. This is a casual book review of the book, Superbugs, An Arms Race Against Bacteria, written by William Hall, Anthony McDonnell and Jim O'Neill published by Harvard University Press, copyright 2018. After being gifted the book, host, Angela Stoyanovitch, falls in love with the topic of antibiotics, a category type of legal drugs. According to the book, Superbugs, approximately 1.5 million people die every year already as a result of antimicrobial resistance. The antibiotic crisis is still developing today.  Is it possible that many of us have abused antibiotics at some point? Are the right diagnostic tests in place within our health care provider systems? What's happening worldwide with resistant strains of bacteria? Do we even know what bacterial strains we are handling or up against as the bacteria evolves so rapidly? What responsibility do we have as individuals? What role does or should our governments play? What about the drug development industry or pharmaceutical companies? In order to understand this issue more fully, perhaps a systems thinking approach should be taken (a reference from a book titled, Thinking in Systems: A Primer, written by Donella Meadows.) As with any drug development topic, this one is complex but applicable to our everyday lives.  Listen in to learn more about Superbugs and potential solutions to this silent killer that include simple human behavioral changes such as hand washing up to a massive cry for global government, pharmaceutical and academic collaboration and funding for new legal drugs, etc.  This episode of Legal Drugs Podcast edited by Margaret Beveridge.